American Regent, Inc. v. Apotex, Inc. et al
| American Regent, Inc. |
| Apotex, Inc. and Apotex Corp. |
| 1:2024cv00327 |
| March 13, 2024 |
| U.S. District Court for the District of Delaware |
| Stephanos Bibas |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 11, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 8
ORDER: DESIGNATION OF CIRCUIT JUDGE TO HOLD A DISTRICT COURT WITHIN THE CIRCUIT, designating and assigning the Honorable Stephanos Bibas of the United States Court of Appeals for the Third Circuit. Signed by Judge Michael A Chagares, Chief Judge of the United States Court of Appeals for the Third Circuit on 4/11/2024. (rjb)
|
| Case Reassigned to Judge Stephanos Bibas of the United States Court of Appeals for the Third Circuit. Please include the initials of the Judge (SB) after the case number on all documents filed. (rjb) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Filing 7 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,786,548 "Corrected". (Viceconte, Christopher) |
| CORRECTING ENTRY: Counsel is advised to refile their AO 120 Patent form with the proper event code in order for the Patent and and Trademark Office to be notified. Previous entry has been removed. (smg) |
| Filing 6 Summons Issued as to Apotex Corp. on 3/13/2024; Apotex, Inc. on 3/13/2024. (Attachments: #1 Summons Issued)(mpb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo Company, Limited, Corporate Parent Daiichi Sankyo, Inc., Corporate Parent Daiichi Sankyo U.S. Holdings, Inc. for American Regent, Inc. filed by American Regent, Inc.. (mpb) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,786,548. (mpb) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/31/2024. Date of Expiration of Patent: 7/1/2041.Thirty Month Stay Deadline: 7/31/2026. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT filed against Apotex Corp., Apotex, Inc. ( Filing fee $ 405, receipt number ADEDC-4360223.) - filed by American Regent, Inc.. (Attachments: #1 Exhibit 1, #2 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
